Hu YH, Liu YL, Meng LF, Zhang YX, Cui WP. Selection of dialysis methods for end-stage kidney disease patients with diabetes. World J Diabetes 2024; 15(9): 1862-1873 [DOI: 10.4239/wjd.v15.i9.1862]
Corresponding Author of This Article
Wen-Peng Cui, MD, PhD, Doctor, Professor, Department of Nephrology, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, Jilin Province, China. wenpengcui@163.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Sep 15, 2024; 15(9): 1862-1873 Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1862
Selection of dialysis methods for end-stage kidney disease patients with diabetes
Yao-Hua Hu, Ya-Li Liu, Ling-Fei Meng, Yi-Xian Zhang, Wen-Peng Cui
Yao-Hua Hu, Ya-Li Liu, Ling-Fei Meng, Yi-Xian Zhang, Wen-Peng Cui, Department of Nephrology, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, China
Author contributions: Hu YH wrote the main manuscript text; Liu YL and Zhang YX prepared tables 1-2; Meng LF participated in revising the manuscript; Cui WP designed this study and reviewed this manuscript.
Supported byScience and Technology Department of Jilin Province, No. YDZJ202201ZYTS110 and No. 20200201352JC.
Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Peng Cui, MD, PhD, Doctor, Professor, Department of Nephrology, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, Jilin Province, China. wenpengcui@163.com
Received: May 8, 2024 Revised: July 3, 2024 Accepted: July 29, 2024 Published online: September 15, 2024 Processing time: 111 Days and 2.3 Hours
Abstract
The increasing prevalence of diabetes has led to a growing population of end-stage kidney disease (ESKD) patients with diabetes. Currently, kidney transplantation is the best treatment option for ESKD patients; however, it is limited by the lack of donors. Therefore, dialysis has become the standard treatment for ESKD patients. However, the optimal dialysis method for diabetic ESKD patients remains controversial. ESKD patients with diabetes often present with complex conditions and numerous complications. Furthermore, these patients face a high risk of infection and technical failure, are more susceptible to malnutrition, have difficulty establishing vascular access, and experience more frequent blood sugar fluctuations than the general population. Therefore, this article reviews nine critical aspects: Survival rate, glucose metabolism disorder, infectious complications, cardiovascular events, residual renal function, quality of life, economic benefits, malnutrition, and volume load. This study aims to assist clinicians in selecting individualized treatment methods by comparing the advantages and disadvantages of hemodialysis and peritoneal dialysis, thereby improving patients’ quality of life and survival rates.
Core Tip: The prevalence of diabetes is leading to an increase in the number of End-stage kidney disease (ESKD) patients with diabetes. Dialysis is the most commonly accepted treatment for ESKD patients. However, the optimal dialysis method for diabetic ESKD patients remains controversial. Diabetic ESKD patients often present with complex conditions and numerous complications. This article reviews recent literature on renal replacement therapy to determine the most suitable dialysis method for diabetic ESKD patients. This review is the first to evaluate the benefits of different dialysis types for diabetic ESKD patients across nine aspects.
